Rasagiline Tablet
Product Images NDC 67877-259

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 67877-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline-str-1 (Rasagiline Str 1)

Chemical structure diagram of Rasagiline, showing its molecular components including a bicyclic structure and sulfonic acid group (CH3SO3H).*

FDA Label Image

Rasagiline-tab-0.5mg-30s (Rasagiline Tab 0.5mg 30s)

Label for Rasagiline Tablets 0.5 mg by Ascend Laboratories, LLC, NDC 67877-259-30. The oral tablet package contains 30 tablets. The label notes rasagiline mesylate equivalent to 0.5 mg rasagiline per tablet, with storage instructions and manufacturer information for Alkem Laboratories Ltd., Mumbai, India.*

FDA Label Image

Rasagiline-tab-1mg-30s (Rasagiline Tab 1mg 30s)

Label for Rasagiline Tablets 1 mg oral tablets by Ascend Laboratories, LLC. The label states the dosage strength of 1 mg and package count of 30 tablets. It includes manufacturer information listing Alkem Laboratories Ltd., Mumbai, India, and distributor details. Storage instructions and a barcode are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.